Onesource Specialty Pharma Secures Renewal of EU-GMP Certification for Flagship Unit II Facility
Onesource Specialty Pharma Limited announced that it has successfully renewed the European Union Good Manufacturing Practices (EU-GMP) certification for its Unit II manufacturing facility. The renewal followed an inspection conducted by a European regulatory authority.The flagship Unit II facility, situated in Bengaluru, represents a key manufacturing site for the company. The facility is equipped for integrated biologics drug-substance and drug-product manufacturing, providing specialized capabilities in drug-device combinations and sterile injectable products.
The successful renewal of this EU-GMP certification underscores the company's commitment to maintaining international quality standards for its pharmaceutical operations.
ONESOURCE Stock Price Movement
Today, Onesource Specialty Pharma Limited shares edged higher to close at ₹1543.5, gaining 2.24% for the session. The stock settled on a total volume of 347,698 shares, signaling a positive day for the pharmaceutical maker.Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.